Related Experiment Video
Updated: Oct 24, 2025

06:36
Lower Limb Biomechanical Analysis of Healthy Participants
Published on: April 15, 2020
9.3K
Leg Muscle Strength Correlates with Gait Performance in Advanced Parkinson Disease
Akira Yokote1,2, Yuka Hayashi1,2, Shozaburo Yanamoto1,2
1Department of Neurology, Fukuseikai Minami Hospital, Japan.
Internal Medicine (Tokyo, Japan)
|August 16, 2021
Summary
Leg muscle strength is linked to mobility and daily function in advanced Parkinson disease (PD). Lower strength predicts disease progression and impacts gait velocity and independence.
Area of Science:
- Neurology
- Gerontology
- Rehabilitation Medicine
Background:
- Leg muscle strength (LMS) declines in early Parkinson disease (PD), impacting mobility and fall risk.
- LMS in advanced PD stages remains under-investigated, necessitating further research.
Purpose of the Study:
- To assess leg muscle strength (LMS) in advanced Parkinson disease (PD) patients (Hoehn and Yahr stages 3-4).
- To investigate the relationship between LMS and gait performance, activities of daily living, and cognitive function in advanced PD.
Main Methods:
- Retrospective review of 132 advanced PD patients (mean disease duration 9.6 years).
- Measurement of leg extensor muscle strength using Strength Ergo 240.
- Analysis of associations between LMS and clinical/functional measures (gait, Barthel index, MMSE, H&Y stage).
Main Results:
- LMS correlated significantly with sex, age, disease onset age, H&Y stage, Barthel index, MMSE score, and gait parameters.
- Gait velocity, Barthel index, sex, and disease duration were significant predictors of LMS.
- LMS demonstrated a strong ability to discriminate between Hoehn and Yahr stages 3 and 4 (AUC=0.774).
Conclusions:
- Leg muscle strength is closely associated with gait velocity and functional independence (Barthel index) in advanced PD.
- LMS may serve as a valuable indicator for predicting Parkinson disease progression.
Related Concept Videos
Parkinson's Disease: Overview
981
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
981
Parkinson's Disease: Treatment
562
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
562

